Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers December 19, 2018
Pharmacy Choice - Pharmaceutical News - Cardiac Insight raises $4.5M, wins FDA approval to launch wearable ECG sensor [Tehran Times (Iran)] - December 19, 2018

Pharmacy News Article

 4/21/17 - Cardiac Insight raises $4.5M, wins FDA approval to launch wearable ECG sensor [Tehran Times (Iran)]

Consumer wearables, like smart watches and Fitbits, are becoming ever more popular. But wearable medical technology has remained somewhat absent from the scene, despite huge potential for improving patient care and potentially lowering healthcare costs.

Kirkland, Wash.-based Cardiac Insight is hoping to break into that market with Cardea Solo, a lightweight disposable electrocardiogram (ECG) test that monitors a patients heartbeat. The company has raised $4.5 million to develop and commercialize the device and announced today that it has been approved for use by the FDA and is now available to healthcare providers.

The company has raised $4.5 million to develop and commercialize the device and announced today that it has been approved for use by the FDA and is now available to healthcare providers. Several existing private investors took part in the round.

Cardiac Insight has been developing Cardeo Solo for several years, and it could reportedly cost as little as $20, making it highly accessible to patients.

The Cardea Solo can be used to monitor the cardiac health of patients who have transient symptoms, like periodic lightheadedness or chest pains, which cannot be replicated in a doctors office, Harlow said

Its a very small, disposable monitor, Harlow said. A person can wear it for seven days, they can shower with it. Its worn under the clothing and its very light, so you wouldnt observe it if someone was wearing it.

The patient would then take the device back to the physician, who can print out a review of the patients heartbeat over the time it was worn, Harlow said. The report can help doctors identify irregularities like atrial fibrillation or tachycardia, both of which can be signs of serious heart problems. The device is now available for purchase by care providers.

A wearable ECG test is also produced by the San Francisco-based iRhythm, which went public in October. Unlike Cardiac Insight, iRhythm sells the test as a service instead of a device, acting as a go-between for patients and doctors.

Cardiac Insight was spun out of the University of Washington in 2008 by Harlow and UW cardiologist David Linker, and their first product the CardeaScreen, a device which tests for heart problems in young athletes was brought to market last year.



(c) 2017 TehranTimes. All Rights Reserved. Provided by SyndiGate Media Inc. (Syndigate.info).

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

LIVE ONLINE CE

Last Chance
Dec 19: Efficacy vs. Safety: Treating BPH & Incontinence in the Elderly
Last Chance
Dec 20: Adult Immunizations: A Guide for Pharmacists, Techs & NPs
Dec 27: Medical Marijuana: The Basic and Clinical Pharmacology, Not The Politics
Jan 02: School is Out! Life is in Session: The Importance of Professional Development in Pharmacy
Jan 03: Management of Bipolar Disorder
Click for entire Webinar Calendar

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...

Nursing Jobs
Are you a nurse looking for a job?

Check out the Nursing Job Source.

Your number one choice for nursing jobs.



Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2018 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415